Treatment of adults Ph+ALL with dasatinb in induction and maintenance therathpy followed by allogeneic HSCT: A multicenter, no controll, prospective stduy.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Dasatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 14 Mar 2017 New trial record